University of San Francisco

Academic/Hospital

Also known as: UCSF School of Medicine: UCSF Diabetes Clinic | University of San Francisco | University of San Francisco School of Pharmacy, San Francisco, CA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

May 30, 2016

Last known activity

Dec 1, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (12 distinct, 4 trials)

Phase 3 (9 own, 0 via acquisition)

ethambutol
rifampin
pyrazinamide
rifapentine
cetuximab
moxifloxacin
isoniazid
pyridoxine
hafnium oxide

Phase 2 (2 own, 0 via acquisition)

enzalutamide
for46

Phase 1 (1 own, 0 via acquisition)

autologous regulatory t cells

Indications

Studied for

Pemphigus
Tuberculosis

Recent trials (4)

NCT05011188Overall official - principal investigatorPhase 1/Phase 2Dec 1, 2021
NCT04892173Overall official - principal investigatorPhase 3Jul 31, 2021
NCT03239470Study chairPhase 1Sep 22, 2017
NCT02563327Study chairPhase 3May 30, 2016

Details

Last known activity: Dec 1, 2021